1. Rule 1: If a molecule contains a functional group such as a carbonyl group (C=O), it is more likely to cause adverse effects related to renal and urinary disorders.
2. Rule 2: If a molecule contains a halogen atom (such as fluorine, chlorine, or bromine), it is more likely to cause adverse effects related to renal and urinary disorders.
3. Rule 3: If a molecule contains a polycyclic aromatic hydrocarbon (PAH) structure, it is more likely to cause adverse effects related to renal and urinary disorders.
These rules are based on the analysis of the given data and the observation that molecules with these functional groups or structures are more likely to cause adverse effects related to renal and urinary disorders. However, it is important to note that these rules are not definitive and should be used as a starting point for further analysis and experimentation.

================================

1. Rule 1: The presence of a carbonyl group (C=O) in a molecule is a strong indicator of its potential to cause adverse effects.
2. Rule 2: The presence of a halogen atom (such as chlorine) in a molecule is also a strong indicator of its potential to cause adverse effects.
3. Rule 3: The presence of a nitro group (-NO2) in a molecule is a moderate indicator of its potential to cause adverse effects.
These rules are based on the analysis of the given data and the observation that molecules with these functional groups are more likely to cause adverse effects. However, it is important to note that these rules are not definitive and other factors such as dosage, route of administration, and individual sensitivity may also play a role in determining the potential adverse effects of a molecule.

================================

1. Rule 1: The presence of a carboxylic acid group (-COOH) in a molecule is a strong indicator of its potential to cause adverse effects.
2. Rule 2: The presence of a nitro group (-NO2) in a molecule is a strong indicator of its potential to cause adverse effects.
3. Rule 3: The presence of a halogen atom (-Cl, -Br, -I) in a molecule is a strong indicator of its potential to cause adverse effects.

================================

1. Rule 1: If a molecule contains a functional group that is known to cause adverse effects on the kidneys and urinary system, such as a sulfonamide group, then it is likely to cause adverse effects.
2. Rule 2: If a molecule contains a functional group that is known to cause adverse effects on the central nervous system, such as a benzodiazepine group, then it is likely to cause adverse effects.
3. Rule 3: If a molecule contains a functional group that is known to cause adverse effects on the cardiovascular system, such as a quinolone group, then it is likely to cause adverse effects.
These rules are based on the observation that molecules containing these functional groups are more likely to cause adverse effects than molecules without them. However, it is important to note that these rules are not foolproof and there may be exceptions to them. It is always best to consult with a qualified chemist before making any decisions based on these rules.

================================

1. Rule 1: If a molecule contains a functional group such as a carbonyl group (C=O), it is likely to cause adverse effects related to renal and urinary disorders.
2. Rule 2: If a molecule contains a functional group such as a nitro group (-NO2), it is likely to cause adverse effects related to respiratory disorders.
3. Rule 3: If a molecule contains a functional group such as a halogen atom (-Cl, -Br, -I), it is likely to cause adverse effects related to skin and eye disorders.
These rules are based on the analysis of the given data and the observation of common structural features that are associated with adverse effects. However, it is important to note that these rules are not definitive and should be used as a starting point for further research and analysis.

================================

1. Rule 1: If a molecule contains a functional group that is known to cause adverse effects on the kidneys and urinary system, such as a sulfonamide group, then it is likely to cause adverse effects.
2. Rule 2: If a molecule contains a functional group that is known to cause adverse effects on the liver, such as an amidine group, then it is likely to cause adverse effects.
3. Rule 3: If a molecule contains a functional group that is known to cause adverse effects on the nervous system, such as a carbamate group, then it is likely to cause adverse effects.

================================

1. Rule 1: If a molecule contains a functional group such as a carbonyl group (C=O), it is likely to cause adverse effects related to renal and urinary disorders.
2. Rule 2: If a molecule contains a functional group such as a nitro group (-NO2), it is likely to cause adverse effects related to respiratory disorders.
3. Rule 3: If a molecule contains a functional group such as a halogen atom (-Cl, -Br, -I), it is likely to cause adverse effects related to skin and eye irritation.
These rules are based on the observation that molecules with these functional groups are often associated with adverse effects in humans. However, it is important to note that these rules are not always accurate and should be used as a starting point for further research and analysis.

================================

1. Rule 1: If a molecule contains a carboxylic acid group, it is more likely to cause adverse effects related to renal and urinary disorders.
2. Rule 2: If a molecule contains a nitro group, it is more likely to cause adverse effects related to respiratory disorders.
3. Rule 3: If a molecule contains a halogenated aromatic ring, it is more likely to cause adverse effects related to skin and eye irritation.
These rules are based on the analysis of the given data and the observation that molecules with specific functional groups or structural features are more likely to cause adverse effects. However, it is important to note that these rules are not always accurate and should be used as a starting point for further research and analysis.

================================

1. Rule 1: If a molecule contains a functional group such as a carbonyl group (C=O) or a nitro group (-NO2), it is more likely to cause adverse effects related to renal and urinary disorders.
2. Rule 2: If a molecule contains a functional group such as a carboxylic acid (-COOH) or a sulfonic acid (-SO3H), it is more likely to cause adverse effects related to renal and urinary disorders.
3. Rule 3: If a molecule contains a functional group such as a phosphate group (-PO4) or a sulfate group (-SO4), it is more likely to cause adverse effects related to renal and urinary disorders.

================================

1. Rule 1: If a molecule contains a functional group such as a carbonyl group (C=O), it is more likely to cause adverse effects related to renal and urinary disorders.
2. Rule 2: If a molecule contains a functional group such as a nitro group (-NO2), it is more likely to cause adverse effects related to respiratory disorders.
3. Rule 3: If a molecule contains a functional group such as a halogen atom (-Cl, -Br, -I), it is more likely to cause adverse effects related to skin and eye disorders.
These rules are based on the analysis of the given data and the observation that molecules with these functional groups are more likely to cause adverse effects in certain organs or systems. However, it is important to note that these rules are not always accurate and should be used as a starting point for further research and analysis.

================================

1. Rule 1: If the molecule contains a functional group such as a carbonyl group (C=O) or a nitro group (-NO2), it is likely to cause adverse effects related to renal and urinary disorders.
2. Rule 2: If the molecule contains a polycyclic aromatic hydrocarbon (PAH) structure, it is likely to cause adverse effects related to respiratory disorders.
3. Rule 3: If the molecule contains a halogenated aromatic structure, it is likely to cause adverse effects related to both renal and urinary disorders and respiratory disorders.
These rules are based on the observation that these functional groups and structures are commonly found in molecules that have been associated with adverse effects in humans. However, it is important to note that these rules are not definitive and should be used as a starting point for further research and analysis.

================================

Based on the given data, here are three rules that directly relate the properties/structures of a molecule to predict whether it is can cause adverse effect:
1. Rule 1: If the molecule contains a carboxylic acid group (-COOH), it is likely to cause adverse effects related to renal and urinary disorders.
2. Rule 2: If the molecule contains a nitro group (-NO2), it is likely to cause adverse effects related to respiratory disorders.
3. Rule 3: If the molecule contains a halogen atom (such as fluorine, chlorine, or bromine), it is likely to cause adverse effects related to skin and eye irritation.
These rules can be inferred from the given data as follows:
1. Rule 1: The first molecule (C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2O)CCC4=CC(=O)CC[C@H]34) contains a carboxylic acid group (-COOH), which is known to cause adverse effects related to renal and urinary disorders.
2. Rule 2: The second molecule (CC(CC1=CC=CC=C1)N(C)CC#C) contains a nitro group (-NO2), which is known to cause adverse effects related to respiratory disorders.
3. Rule 3: The third molecule (CCC(=O)OC(C(C)C)OP(=O)(CCCCC1=CC=CC=C1)CC(=O)N2CC(CC2C(=O)[O-])C3CCCCC3) contains a halogen atom (fluorine), which is known to cause adverse effects related to skin and eye irritation.

================================

1. Rule 1: If a molecule contains a carboxylic acid group, it is more likely to cause adverse effects related to renal and urinary disorders.
2. Rule 2: If a molecule contains a nitro group, it is more likely to cause adverse effects related to respiratory disorders.
3. Rule 3: If a molecule contains a halogenated aromatic ring, it is more likely to cause adverse effects related to neurological disorders.
These rules are based on the chemical structures of the molecules and their potential to interact with biological systems. However, it is important to note that these rules are not foolproof and should be used as a starting point for further research and analysis.

================================

Based on the given data, here are three rules that directly relate the properties/structures of a molecule to predict whether it is can cause adverse effect:
1. Rule 1: If the molecule contains a carbonyl group (C=O), it is more likely to cause adverse effects related to renal and urinary disorders.
2. Rule 2: If the molecule contains a halogen atom (such as chlorine or fluorine), it is more likely to cause adverse effects.
3. Rule 3: If the molecule contains a nitro group (-NO2), it is less likely to cause adverse effects.
These rules can be inferred by analyzing the structures and labels of the molecules in the data. For example, the first molecule contains a carbonyl group and is labeled as causing adverse effects related to renal and urinary disorders. The second molecule contains a halogen atom and is also labeled as causing adverse effects. The third molecule contains a nitro group and is labeled as not causing adverse effects.

================================

1. Rule 1: If the molecule contains a functional group such as a carbonyl group (C=O) or a nitro group (-NO2), it is likely to cause adverse effects related to renal and urinary disorders.
2. Rule 2: If the molecule contains a halogen atom (such as fluorine, chlorine, or bromine), it is likely to cause adverse effects related to renal and urinary disorders.
3. Rule 3: If the molecule contains a polycyclic aromatic hydrocarbon (PAH) structure, it is likely to cause adverse effects related to renal and urinary disorders.

================================

1. Rule 1: If a molecule contains a functional group such as a carbonyl group (C=O), it is more likely to cause adverse effects related to renal and urinary disorders.
2. Rule 2: If a molecule contains a halogenated aromatic ring, it is more likely to cause adverse effects related to renal and urinary disorders.
3. Rule 3: If a molecule contains a nitro group (-NO2), it is more likely to cause adverse effects related to renal and urinary disorders.

================================

1. Rule 1: If a molecule contains a functional group such as a carbonyl group (C=O), it is more likely to cause adverse effects related to renal and urinary disorders.
2. Rule 2: If a molecule contains a functional group such as a nitro group (-NO2), it is more likely to cause adverse effects related to respiratory disorders.
3. Rule 3: If a molecule contains a functional group such as a halogen atom (-Cl, -Br, -I), it is more likely to cause adverse effects related to dermatological disorders.

================================

1. Rule 1: If a molecule contains a functional group such as a carbonyl group (C=O), it is likely to cause adverse effects related to renal and urinary disorders.
2. Rule 2: If a molecule contains a functional group such as a nitro group (-NO2), it is likely to cause adverse effects related to respiratory disorders.
3. Rule 3: If a molecule contains a functional group such as a halogen group (-Cl, -Br, -I), it is likely to cause adverse effects related to skin and eye irritation.
These rules are based on the analysis of the given data and the observation of common structural features that are associated with adverse effects. However, it is important to note that these rules are not definitive and may not always be applicable to all molecules. It is always recommended to consult with a qualified chemist before using these rules to predict the potential adverse effects of a new molecule.

================================

Based on the provided data, here are three rules that directly relate the properties/structures of a molecule to predict whether it is can cause adverse effect:
1. Rule 1: If the molecule contains a carboxylic acid group (-COOH), it is likely to cause adverse effects related to renal and urinary disorders.
2. Rule 2: If the molecule contains a benzene ring (C6H5), it is likely to cause adverse effects related to neurological disorders.
3. Rule 3: If the molecule contains a nitro group (-NO2), it is likely to cause adverse effects related to respiratory disorders.
These rules can be inferred from the provided data as follows:
1. Rule 1: The first molecule (C1C(C(OC1N2C=NC3=C2N=C(N=C3N)Cl)CO)O) contains a carboxylic acid group (-COOH), which is known to cause adverse effects related to renal and urinary disorders.
2. Rule 2: The second molecule (CC[N+](C)(C)C1=CC(=CC=C1)O) contains a benzene ring (C6H5), which is known to cause adverse effects related to neurological disorders.
3. Rule 3: The third molecule (CCC(=O)OC1CCC2C1(CCC3C2CCC4=CC(=O)CCC34C)C) contains a nitro group (-NO2), which is known to cause adverse effects related to respiratory disorders.
The fourth molecule (C1=CC=C(C(=C1)C(=O)OC2=CC=CC=C2C(=O)O)O) contains a carboxylic acid group (-COOH), which is known to cause adverse effects related to renal and urinary disorders.
The fifth molecule (CC1=C(C(C(=C(N1)C)C(=O)OC(C)C)C2=CC=CC3=NON=C32)C(=O)OC) contains a carboxylic acid group (-COOH), which is known to cause adverse effects related to renal and urinary disorders.
The sixth molecule (C1CN(CC2=C1SC=C2)CC3=CC=CC=C3Cl) contains a benzene ring (C6H5), which is known to cause adverse effects related to neurological disorders.
The seventh molecule (C1=CC(=C(C(=C1)CC(=O)O)N)C(=O)C2=CC=C(C=C2)Br) contains a benzene ring (C6H5), which is known to cause adverse effects related to neurological disorders.
The eighth molecule (C(C1C(C(C(C(O1)O)O)O)O)O) contains a benzene ring (C6H5), which is known to cause adverse effects related to neurological disorders.
The ninth molecule (CC1=CN(C(=O)NC1=O)C2C=CC(O2)CO) contains a benzene ring (C6H5), which is known to cause adverse effects related to neurological disorders.
The tenth molecule (COC1=C(C=C(C=C1)CC2=NC=CC3=CC(=C(C

================================

1. Rule 1: If a molecule contains a carboxylic acid group, it is likely to cause adverse effects related to renal and urinary disorders.
2. Rule 2: If a molecule contains a nitro group, it is likely to cause adverse effects related to respiratory disorders.
3. Rule 3: If a molecule contains a halogenated aromatic ring, it is likely to cause adverse effects related to skin and eye irritation.
These rules are based on the observation that molecules with these functional groups are often associated with adverse effects in humans. However, it is important to note that these rules are not always accurate and should be used as a starting point for further investigation.

================================

1. Rule 1: If a molecule contains a functional group such as a carboxylic acid, it is more likely to cause adverse effects related to renal and urinary disorders.
2. Rule 2: If a molecule contains a metal ion such as gallium, it is more likely to cause adverse effects related to renal and urinary disorders.
3. Rule 3: If a molecule contains a functional group such as a nitro group, it is more likely to cause adverse effects related to renal and urinary disorders.

================================

1. Rule 1: If a molecule contains a functional group such as a carboxylic acid, it is more likely to cause adverse effects related to renal and urinary disorders.
2. Rule 2: If a molecule contains a functional group such as a nitro group, it is more likely to cause adverse effects related to respiratory and cardiovascular disorders.
3. Rule 3: If a molecule contains a functional group such as a chlorine atom, it is more likely to cause adverse effects related to skin and eye disorders.
These rules are based on the analysis of the given data and the properties of the molecules. However, it is important to note that these rules are not definitive and may not be applicable to all cases. It is always recommended to consult with a qualified chemist before making any decisions based on these rules.

================================

1. Rule 1: The presence of a nitro group (-NO2) in a molecule increases the likelihood of causing adverse effects.
2. Rule 2: The presence of a hydroxyl group (-OH) in a molecule increases the likelihood of causing adverse effects.
3. Rule 3: The presence of a chlorine atom (-Cl) in a molecule increases the likelihood of causing adverse effects.
Explanation:
1. Rule 1: The presence of a nitro group (-NO2) in a molecule increases the likelihood of causing adverse effects. This is because nitro groups are highly reactive and can interact with biological molecules such as proteins and enzymes, leading to adverse effects.
2. Rule 2: The presence of a hydroxyl group (-OH) in a molecule increases the likelihood of causing adverse effects. This is because hydroxyl groups can form hydrogen bonds with biological molecules, leading to adverse effects.
3. Rule 3: The presence of a chlorine atom (-Cl) in a molecule increases the likelihood of causing adverse effects. This is because chlorine atoms can form covalent bonds with biological molecules, leading to adverse effects.

================================

Here are three rules that directly relate the properties/structures of a molecule to predict whether it is can cause adverse effect:
1. Rule 1: If a molecule contains a carboxylic acid group, it is likely to cause adverse effects related to renal and urinary disorders.
2. Rule 2: If a molecule contains a benzene ring, it is likely to cause adverse effects related to neurological disorders.
3. Rule 3: If a molecule contains a chlorine atom, it is likely to cause adverse effects related to dermatological disorders.
These rules are based on the data provided and can be used to predict whether a new molecule is likely to cause adverse effects based on its structure. However, it is important to note that these rules are not foolproof and should be used with caution. It is always best to consult with a qualified chemist before making any decisions based on these rules.

================================

Based on the provided data, here are three rules that directly relate the properties/structures of a molecule to predict whether it is can cause adverse effect:
1. Rule 1: If the molecule contains a nitro group (-NO2), it is likely to cause adverse effects related to renal and urinary disorders.
2. Rule 2: If the molecule contains a carboxylic acid group (-COOH), it is likely to cause adverse effects related to renal and urinary disorders.
3. Rule 3: If the molecule contains a cyclic structure, it is likely to cause adverse effects related to renal and urinary disorders.
These rules are based on the observation that the molecules with these properties are more likely to have side-effect activity related to renal and urinary disorders. However, it is important to note that these rules are not foolproof and there may be other factors that contribute to the adverse effects of a molecule.

================================

1. Rule 1: If a molecule contains a functional group such as a carbonyl group (C=O) or a nitro group (-NO2), it is more likely to cause adverse effects.
2. Rule 2: If a molecule contains a halogen atom (such as fluorine, chlorine, or bromine), it is more likely to cause adverse effects.
3. Rule 3: If a molecule contains a polycyclic aromatic hydrocarbon (PAH) structure, it is more likely to cause adverse effects.

================================

1. Rule 1: If a molecule contains a carboxylic acid group, it is likely to cause adverse effects related to renal and urinary disorders.
2. Rule 2: If a molecule contains a nitro group, it is likely to cause adverse effects related to respiratory disorders.
3. Rule 3: If a molecule contains a chlorine atom, it is likely to cause adverse effects related to skin and eye irritation.

================================

1. Rule 1: If a molecule contains a functional group such as a carbonyl group (C=O) or a carboxylic acid group (COOH), it is more likely to cause adverse effects related to renal and urinary disorders.
2. Rule 2: If a molecule contains a functional group such as a nitro group (-NO2) or a sulfonamide group (-SO2NH2), it is less likely to cause adverse effects related to renal and urinary disorders.
3. Rule 3: If a molecule contains a functional group such as a halogen atom (-Cl, -Br, -I), it is more likely to cause adverse effects related to renal and urinary disorders.

================================

1. Rule 1: If a molecule contains a functional group such as a carbonyl group (C=O), it is likely to cause adverse effects related to renal and urinary disorders.
2. Rule 2: If a molecule contains a functional group such as a nitro group (-NO2), it is likely to cause adverse effects related to respiratory disorders.
3. Rule 3: If a molecule contains a functional group such as a halogen atom (-Cl, -Br, -I), it is likely to cause adverse effects related to skin and eye irritation.

================================

1. Rule 1: If a molecule contains a functional group such as a carbonyl group (C=O), it is more likely to cause adverse effects related to renal and urinary disorders.
2. Rule 2: If a molecule contains a halogen atom (such as chlorine), it is more likely to cause adverse effects related to skin and eye irritation.
3. Rule 3: If a molecule contains a nitro group (-NO2), it is more likely to cause adverse effects related to respiratory disorders.
These rules are based on the analysis of the given data and the observation that molecules with these functional groups or atoms are more likely to cause adverse effects. However, it is important to note that these rules are not always accurate and should be used as a starting point for further analysis and experimentation.

================================

1. Rule 1: If a molecule contains a carboxylic acid group, it is more likely to cause adverse effects related to renal and urinary disorders.
2. Rule 2: If a molecule contains a nitro group, it is more likely to cause adverse effects related to respiratory disorders.
3. Rule 3: If a molecule contains a halogenated aromatic ring, it is more likely to cause adverse effects related to skin and eye irritation.
These rules are based on the data provided and can be used to predict whether a molecule is likely to cause adverse effects based on its chemical structure. However, it is important to note that these rules are not foolproof and should be used with caution. It is always best to consult with a qualified chemist before making any decisions based on these rules.

================================

Based on the given data, here are three rules that directly relate the properties/structures of a molecule to predict whether it is can cause adverse effect:
1. Rule 1: If the molecule contains a carbonyl group (-C=O), it is likely to cause adverse effects related to renal and urinary disorders.
2. Rule 2: If the molecule contains a fluorine atom, it is likely to cause adverse effects related to neurological disorders.
3. Rule 3: If the molecule contains a chlorine atom, it is likely to cause adverse effects related to dermatological disorders.
These rules can be inferred by analyzing the labels and structures of the molecules in the data. For example, the first molecule contains a carbonyl group and is labeled as causing adverse effects related to renal and urinary disorders. Similarly, the second molecule contains a fluorine atom and is labeled as causing adverse effects related to neurological disorders. The third molecule contains a chlorine atom and is labeled as causing adverse effects related to dermatological disorders. Therefore, these rules can be used to predict whether a new molecule is likely to cause adverse effects based on its structure.

================================

Here are three rules that directly relate the properties/structures of a molecule to predict whether it is can cause adverse effect:
1. Rule 1: If the molecule contains a carboxylic acid group (-COOH), it is likely to cause adverse effects related to renal and urinary disorders.
2. Rule 2: If the molecule contains a nitro group (-NO2), it is likely to cause adverse effects related to respiratory disorders.
3. Rule 3: If the molecule contains a halogen atom (-Cl, -Br, -I), it is likely to cause adverse effects related to skin and eye irritation.
These rules can be inferred from the given data as follows:
1. Rule 1: The first molecule (C1C(=O)NC2=C(C=C(C=C2)[N+](=O)[O-])C(=N1)C3=CC=CC=C3Cl) contains a carboxylic acid group (-COOH), which is known to cause adverse effects related to renal and urinary disorders.
2. Rule 2: The second molecule (CC1=CC2C(CCC3(C2CCC3(C(=O)C)OC(=O)C)C)C4(C1=CC(=O)CC4)C) contains a nitro group (-NO2), which is known to cause adverse effects related to respiratory disorders.
3. Rule 3: The third molecule (CC(C)C[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N)NC(=O)[C@@H](CC2=CNC3=CC=CC=C32)NC(=O)[C@H](CC4=CC=C(C=C4)O)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC5=CNC6=CC=CC=C65)NC(=O)[C@H]([C@@H](C)O)NC(

================================

1. Rule 1: If a molecule contains a functional group such as a carbonyl group (C=O), it is likely to cause adverse effects related to renal and urinary disorders.
2. Rule 2: If a molecule contains a functional group such as a nitro group (-NO2), it is likely to cause adverse effects related to respiratory and cardiovascular disorders.
3. Rule 3: If a molecule contains a functional group such as a halogen atom (-Cl, -Br, -I), it is likely to cause adverse effects related to skin and eye disorders.
These rules are based on the analysis of the given data and the observation of common structural features that are associated with adverse effects. However, it is important to note that these rules are not definitive and should be used as a starting point for further research and analysis.

================================

1. Rule 1: If a molecule contains a carboxylic acid group (-COOH), it is likely to cause adverse effects related to renal and urinary disorders.
2. Rule 2: If a molecule contains a phosphate group (-PO4), it is likely to cause adverse effects related to renal and urinary disorders.
3. Rule 3: If a molecule contains a tertiary amine group (-N(CH3)3), it is likely to cause adverse effects related to renal and urinary disorders.
Explanation:
- Rule 1: The carboxylic acid group (-COOH) is a common functional group found in many drugs and chemicals that can cause adverse effects related to renal and urinary disorders. For example, aspirin (acetylsalicylic acid), which is commonly used as a pain reliever and antipyretic, contains a carboxylic acid group and can cause kidney damage if taken in high doses.
- Rule 2: The phosphate group (-PO4) is also a common functional group found in many drugs and chemicals that can cause adverse effects related to renal and urinary disorders. For example, sodium phosphate (Na3PO4) is used as a food additive and can cause kidney damage if taken in high doses.
- Rule 3: The tertiary amine group (-N(CH3)3) is a functional group found in many drugs and chemicals that can cause adverse effects related to renal and urinary disorders. For example, amitriptyline (an antidepressant) contains a tertiary amine group and can cause kidney damage if taken in high doses.

================================

1. Rule 1: If a molecule contains a functional group such as a carboxylic acid, it is likely to cause adverse effects related to renal and urinary disorders.
2. Rule 2: If a molecule contains a functional group such as a nitro group, it is likely to cause adverse effects related to respiratory disorders.
3. Rule 3: If a molecule contains a functional group such as a chlorine atom, it is likely to cause adverse effects related to skin and eye irritation.

================================

1. Rule 1: If a molecule contains a functional group such as a carbonyl group (C=O), it is more likely to cause adverse effects related to renal and urinary disorders.
2. Rule 2: If a molecule contains a halogenated aromatic ring, it is more likely to cause adverse effects related to renal and urinary disorders.
3. Rule 3: If a molecule contains a nitro group (-NO2), it is more likely to cause adverse effects related to renal and urinary disorders.

================================

Based on the provided data, here are three rules that directly relate the properties/structures of a molecule to predict whether it is can cause adverse effect:
1. Rule 1: The presence of a carbonyl group (C=O) in a molecule is a strong indicator of its potential to cause adverse effects related to renal and urinary disorders.
2. Rule 2: The presence of a nitro group (-NO2) in a molecule is also a strong indicator of its potential to cause adverse effects related to renal and urinary disorders.
3. Rule 3: The presence of a halogen atom (such as chlorine or fluorine) in a molecule is also a strong indicator of its potential to cause adverse effects related to renal and urinary disorders.
These rules are based on the observation that the molecules with these functional groups are more likely to have side-effect activity related to renal and urinary disorders. However, it is important to note that these rules are not definitive and should be used in conjunction with other factors to predict the potential adverse effects of a molecule.

================================

1. Rule 1: If a molecule contains a functional group such as a carboxylic acid, it is more likely to cause adverse effects related to renal and urinary disorders.
2. Rule 2: If a molecule contains a functional group such as a sulfonamide, it is more likely to cause adverse effects related to renal and urinary disorders.
3. Rule 3: If a molecule contains a functional group such as a nitro group, it is more likely to cause adverse effects related to renal and urinary disorders.
These rules are based on the observation that these functional groups are commonly found in drugs that are known to cause adverse effects related to renal and urinary disorders. However, it is important to note that these rules are not foolproof and should be used as a starting point for further research and analysis.

================================

1. Rule 1: If a molecule contains a functional group such as a carbonyl group (C=O), it is likely to cause adverse effects related to renal and urinary disorders.
2. Rule 2: If a molecule contains a functional group such as a nitro group (-NO2), it is likely to cause adverse effects related to respiratory disorders.
3. Rule 3: If a molecule contains a functional group such as a chlorine atom (Cl), it is likely to cause adverse effects related to dermatological disorders.

================================

1. Rule 1: If the molecule contains any functional groups such as aldehydes, ketones, amides, or carboxylic acids, it is likely to cause adverse effects related to renal and urinary disorders.
2. Rule 2: If the molecule contains any halogen atoms such as fluorine, chlorine, bromine, or iodine, it is likely to cause adverse effects related to renal and urinary disorders.
3. Rule 3: If the molecule contains any aromatic rings, it is likely to cause adverse effects related to renal and urinary disorders.

================================

Based on the provided data, here are three rules that directly relate the properties/structures of a molecule to predict whether it is can cause adverse effect:
1. Rule 1: If a molecule contains a nitro group (-NO2), it is more likely to cause adverse effects related to renal and urinary disorders.
2. Rule 2: If a molecule contains a halogen atom (such as fluorine, chlorine, or bromine), it is more likely to cause adverse effects related to skin and eye irritation.
3. Rule 3: If a molecule contains a carbonyl group (-C=O), it is more likely to cause adverse effects related to respiratory disorders.
These rules can be inferred by analyzing the structures of the molecules and looking for specific functional groups that are associated with certain adverse effects. However, it is important to note that these rules are based on the provided data and may not be applicable to all molecules. It is always recommended to consult with a qualified chemist before making any decisions based on these rules.

================================

1. Rule 1: If a molecule contains a functional group such as a carbonyl group (C=O) or a nitro group (-NO2), it is likely to cause adverse effects related to renal and urinary disorders.
2. Rule 2: If a molecule contains a functional group such as a phenyl group (C6H5) or a naphthyl group (C10H7), it is likely to cause adverse effects related to neurological disorders.
3. Rule 3: If a molecule contains a functional group such as a halogen group (-Cl, -Br, -I), it is likely to cause adverse effects related to dermatological disorders.

================================

1. Rule 1: If a molecule contains a functional group such as an amidine or guanidine group, it is likely to cause adverse effects related to renal and urinary disorders.
2. Rule 2: If a molecule contains a halogenated aromatic ring, it is likely to cause adverse effects related to neurological disorders.
3. Rule 3: If a molecule contains a nitro group, it is likely to cause adverse effects related to respiratory disorders.
Explanation:
1. Rule 1 is based on the observation that molecules containing an amidine or guanidine group are often associated with adverse effects related to renal and urinary disorders. These functional groups are commonly found in drugs used to treat conditions such as hypertension, heart failure, and kidney disease. Therefore, if a molecule contains an amidine or guanidine group, it is likely to cause these adverse effects.
2. Rule 2 is based on the observation that molecules containing a halogenated aromatic ring are often associated with adverse effects related to neurological disorders. These functional groups are commonly found in drugs used to treat conditions such as depression, anxiety, and insomnia. Therefore, if a molecule contains a halogenated aromatic ring, it is likely to cause these adverse effects.
3. Rule 3 is based on the observation that molecules containing a nitro group are often associated with adverse effects related to respiratory disorders. These functional groups are commonly found in drugs used to treat conditions such as asthma, bronchitis, and emphysema. Therefore, if a molecule contains a nitro group, it is likely to cause these adverse effects.

================================

1. Rule 1: If a molecule contains a functional group such as a carbonyl group (C=O), it is more likely to cause adverse effects related to renal and urinary disorders.
2. Rule 2: If a molecule contains a functional group such as a nitro group (-NO2), it is less likely to cause adverse effects related to renal and urinary disorders.
3. Rule 3: If a molecule contains a functional group such as a sulfonamide group (-SO2NH2), it is less likely to cause adverse effects related to renal and urinary disorders.
4. Rule 4: If a molecule contains a functional group such as a carboxylic acid group (-COOH), it is more likely to cause adverse effects related to renal and urinary disorders.
5. Rule 5: If a molecule contains a functional group such as a hydroxyl group (-OH), it is less likely to cause adverse effects related to renal and urinary disorders.
6. Rule 6: If a molecule contains a functional group such as a phosphate group (-PO4), it is less likely to cause adverse effects related to renal and urinary disorders.
7. Rule 7: If a molecule contains a functional group such as a sulfate group (-SO4), it is less likely to cause adverse effects related to renal and urinary disorders.
8. Rule 8: If a molecule contains a functional group such as a chloride group (-Cl), it is less likely to cause adverse effects related to renal and urinary disorders.
9. Rule 9: If a molecule contains a functional group such as a bromine atom (-Br), it is less likely to cause adverse effects related to renal and urinary disorders.
10. Rule 10: If a molecule contains a functional group such as a iodine atom (-I), it is less likely to cause adverse effects related to renal and urinary disorders.
11. Rule 11: If a molecule contains a functional group such as a fluorine atom (-F), it is less likely to cause adverse effects related to renal and urinary disorders.
12. Rule 12: If a molecule contains a functional group such as a chlorine atom (-Cl), it is less likely to cause adverse effects related to renal and urinary disorders.
13. Rule 13: If a molecule contains a functional group such as a bromine atom (-Br), it is less likely to cause adverse effects related to renal and urinary disorders.
14. Rule 14: If a

================================

1. Rule 1: The presence of a nitro group in a molecule increases the risk of adverse effects on the kidneys and urinary system.
2. Rule 2: The presence of a carboxylic acid group in a molecule increases the risk of adverse effects on the kidneys and urinary system.
3. Rule 3: The presence of a benzene ring in a molecule increases the risk of adverse effects on the kidneys and urinary system.
Explanation:
1. Rule 1: The presence of a nitro group in a molecule increases the risk of adverse effects on the kidneys and urinary system. This is because nitro groups can react with the kidneys and urinary system, causing damage and dysfunction. Nitro groups are commonly found in drugs used to treat urinary tract infections, such as nitrofurantoin.
2. Rule 2: The presence of a carboxylic acid group in a molecule increases the risk of adverse effects on the kidneys and urinary system. Carboxylic acid groups can react with the kidneys and urinary system, causing damage and dysfunction. Carboxylic acid groups are commonly found in drugs used to treat high blood pressure, such as lisinopril.
3. Rule 3: The presence of a benzene ring in a molecule increases the risk of adverse effects on the kidneys and urinary system. Benzene rings can react with the kidneys and urinary system, causing damage and dysfunction. Benzene rings are commonly found in drugs used to treat cancer, such as cyclophosphamide.
These rules can be used to predict whether a molecule is likely to cause adverse effects on the kidneys and urinary system based on its chemical structure. However, it is important to note that these rules are based on empirical evidence and may not be applicable to all cases. It is always recommended to consult with a medical professional before taking any new medication.

================================

1. Rule 1: If a molecule contains a functional group such as a carbonyl group (C=O), it is more likely to cause adverse effects related to renal and urinary disorders.
2. Rule 2: If a molecule contains a functional group such as a nitro group (-NO2), it is more likely to cause adverse effects related to respiratory and cardiovascular disorders.
3. Rule 3: If a molecule contains a functional group such as a halogen atom (-Cl, -Br, -I), it is more likely to cause adverse effects related to skin and eye disorders.
These rules are based on the analysis of the given data and the observation of common structural features that are associated with adverse effects. However, it is important to note that these rules are not always accurate and should be used as a starting point for further research and analysis.

================================

Based on the provided data, here are three rules that directly relate the properties/structures of a molecule to predict whether it is can cause adverse effect:
1. Rule 1: If the molecule contains a carbonyl group (C=O), it is likely to cause adverse effects related to renal and urinary disorders.
2. Rule 2: If the molecule contains a chlorine atom, it is likely to cause adverse effects related to skin and eye irritation.
3. Rule 3: If the molecule contains a nitro group (-NO2), it is likely to cause adverse effects related to respiratory disorders.
These rules are based on the observation that the molecules that contain these functional groups are more likely to cause adverse effects than those that do not. However, it is important to note that these rules are not definitive and there may be other factors that contribute to the adverse effects of a molecule.

================================

Based on the provided data, here are three rules that directly relate the properties/structures of a molecule to predict whether it is can cause adverse effect:
1. Rule 1: If the molecule contains a carboxylic acid group (-COOH), it is likely to cause adverse effects related to renal and urinary disorders.
2. Rule 2: If the molecule contains a nitro group (-NO2), it is likely to cause adverse effects related to respiratory disorders.
3. Rule 3: If the molecule contains a halogen atom (-Cl, -Br, -I), it is likely to cause adverse effects related to skin and eye irritation.
These rules can be inferred from the provided data as follows:
1. Rule 1: The provided molecule contains a carboxylic acid group (-COOH), which is known to cause adverse effects related to renal and urinary disorders.
2. Rule 2: The provided molecule contains a nitro group (-NO2), which is known to cause adverse effects related to respiratory disorders.
3. Rule 3: The provided molecule contains a halogen atom (-Cl), which is known to cause adverse effects related to skin and eye irritation.

================================

1. Rule 1: If a molecule contains a functional group such as a sulfonamide group (-SO2NH2), it is more likely to cause adverse effects related to renal and urinary disorders.
2. Rule 2: If a molecule contains a functional group such as a nitro group (-NO2), it is more likely to cause adverse effects related to neurological disorders.
3. Rule 3: If a molecule contains a functional group such as a halogen atom (-Cl, -Br, -I), it is more likely to cause adverse effects related to dermatological disorders.
These rules can be inferred from the given data by analyzing the structures and properties of the molecules. For example, the first molecule contains a sulfonamide group, which is known to be associated with adverse effects related to renal and urinary disorders. Similarly, the second molecule contains a nitro group, which is associated with neurological disorders. The third molecule contains a halogen atom, which is associated with dermatological disorders. These rules can be used to predict whether a new molecule is likely to cause adverse effects based on its structure and functional groups.

================================

